Copyright © 2019 Daniela Figueroa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.The combination of doxorubicin and cyclophosphamide commonly used to treat breast cancer can cause premature ovarian failure and infertility. α-Tocopherol is a potent antioxidant whereas γ-tocopherol causes apoptosis in a variety of cancer models in vitro including breast cancer. We hypothesised that the combination of doxorubicin (Dox) and 4-hydroperoxycyclophosphamide (4-Cyc) would be more cytotoxic in vitro than each agent alone, and that α-tocopherol would reduce and γ-tocopherol would ...
Chemotherapy treatment in premenopausal women has been linked to premature ovarian failure (POF), a...
Study hypothesis: Dicoumarol (DC) has potential for use as a gonad-safe anticancer agent. study find...
The purpose of this study was to evaluate the anticancer potency and mechanism of a novel difluorodi...
The combination of doxorubicin and cyclophosphamide commonly used to treat breast cancer can cause p...
Introduction: Breast cancer is one of the most common cancers in women. Current recommendations for ...
Chemotherapy remains a cornerstone among the cancer treatment modalities but the therapeutic effecti...
Doxorubicin (Adriamycin) is the most active drug in the treatment of breast cancer. The aim of this ...
Aim: Ovarian cancer is the third most common gynecological malignancy worldwide. However, it has the...
Purpose: To investigate the anticancer effects of 7-hydroxycoumarin against cisplatin-resistant ovar...
Chemotherapy protocol can destroy the reproductive potential of young cancer patients. Doxorubicin (...
Cancers involving the oral cavity, head, and neck regions are often treated with cisplatin. In cance...
Over 80% of women diagnosed with advanced-stage ovarian cancer die as a result of disease recurrence...
Resistance to some cancer chemotherapeutic drugs has been identifed. One strategy to overcome that p...
Cyclophosphamide (CPA) chemotherapy has been known to cause ovarian failure. CPA therapy leads to in...
Drug resistance remains a major challenge in the treatment of patients with ovarian cancer. Therefor...
Chemotherapy treatment in premenopausal women has been linked to premature ovarian failure (POF), a...
Study hypothesis: Dicoumarol (DC) has potential for use as a gonad-safe anticancer agent. study find...
The purpose of this study was to evaluate the anticancer potency and mechanism of a novel difluorodi...
The combination of doxorubicin and cyclophosphamide commonly used to treat breast cancer can cause p...
Introduction: Breast cancer is one of the most common cancers in women. Current recommendations for ...
Chemotherapy remains a cornerstone among the cancer treatment modalities but the therapeutic effecti...
Doxorubicin (Adriamycin) is the most active drug in the treatment of breast cancer. The aim of this ...
Aim: Ovarian cancer is the third most common gynecological malignancy worldwide. However, it has the...
Purpose: To investigate the anticancer effects of 7-hydroxycoumarin against cisplatin-resistant ovar...
Chemotherapy protocol can destroy the reproductive potential of young cancer patients. Doxorubicin (...
Cancers involving the oral cavity, head, and neck regions are often treated with cisplatin. In cance...
Over 80% of women diagnosed with advanced-stage ovarian cancer die as a result of disease recurrence...
Resistance to some cancer chemotherapeutic drugs has been identifed. One strategy to overcome that p...
Cyclophosphamide (CPA) chemotherapy has been known to cause ovarian failure. CPA therapy leads to in...
Drug resistance remains a major challenge in the treatment of patients with ovarian cancer. Therefor...
Chemotherapy treatment in premenopausal women has been linked to premature ovarian failure (POF), a...
Study hypothesis: Dicoumarol (DC) has potential for use as a gonad-safe anticancer agent. study find...
The purpose of this study was to evaluate the anticancer potency and mechanism of a novel difluorodi...